Untargeted Metabolomic Study for Urinary Characterization of Adult Patients with Phenylketonuria
Authors:
- Arnau Gonzalez-RodriguezAGArnau Gonzalez-Rodriguez
- Blanca Barrau-MartinezBBBlanca Barrau-Martinez
- Adriana PanéAPAdriana Pané
- Rosa Maria López GaleraRGRosa Maria López Galera
- Ester TobiasETEster Tobias
- Cristina Montserrat-CarbonellCMCristina Montserrat-Carbonell
- Mariona Guitart-MampelMGMariona Guitart-Mampel
- Olga JáureguiOJOlga Jáuregui
- Regina Roca-VivesRRRegina Roca-Vives
- Judit Garcia-VilloriaJGJudit Garcia-Villoria
- Jose Cesar MilisendaJMJose Cesar Milisenda
- Ana Matas-GarciaAna Matas-Garcia
Open Access
- 6 December 2025
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (24) , 11808
Abstract
Phenylketonuria (PKU) is a rare inherited metabolic disorder caused by phenylalanine hydroxylase deficiency, leading to phenylalanine (Phe) accumulation and neurological dysfunction if untreated. While metabolomics holds promise for biomarker discovery in PKU, few studies have examined urinary metabolites using untargeted approaches. This study applied untargeted metabolomics using HPLC-QTOF-MS to analyze urine from 36 adult patients with PKU and 34 healthy controls. Biomarker Analysis was performed with MetaboAnalyst 6.0. A total of 73 significant metabolites (FDR < 0.05; VIP > 1) were identified, with 29 upregulated and 44 downregulated in PKU. A 23% of these metabolites were related to Phe metabolism, while 77% were associated with alterations across more than 10 metabolic pathways, including leucine and tryptophan metabolism, acylcarnitines, vitamins, and diet- or microbiota-derived compounds, among others. Specifically, upregulated metabolites with an AUC > 0.9 included several Phe-derived compounds, the nucleoside 8-hydroxy-7-methylguanine, and indole compounds (1H-indole-3-carboxaldehyde). Conversely, downregulated metabolites with an AUC > 0.9 included N-acetyl(iso)leucine and a heptenoylcarnitine isomer. The Random Forest-based model demonstrated enhanced predictive performance when integrating 10 metabolites, supporting their potential utility as biomarkers for PKU. These findings improve the biological understanding of metabolic disturbances beyond Phe, and may support the development of new therapeutic and dietary strategies.Keywords
Funding Information
- Fundació la Marató de TV3 (202014-32, 202014-30)
- Ministerio de Ciencia, Innovación y Universidades, Fondo Europeo de Desarrollo Regional
- Agencia Estatal de Investigación (EQC2019-005533-P)
- INSA joINT rEseaRch ACTions INTERACT 2024
- Instituto de Salud Carlos III (ER24P3AC722, ER25PE04)
- AGAUR-Generalitat de Catalunya (2022 FI_B 01012, 2024 FI-1 00408)
- FPU predoctoral program from the Spanish Ministry of Science, Innovation and Universities (FPU23/03478)
- INSA-UB recognized as a María de Maeztu Unit of Excellence (CEX2021-001234-M, MICIU/AEI/10.13039/501100011033)
This publication has 76 references indexed in Scilit:
- The clinical relevance of novel biomarkers as outcome parameter in adults with phenylketonuriaJournal of Inherited Metabolic Disease, 2024
- Dietary intake of creatine and risk of medical conditions in U.S. older men and women: Data from the 2017–2018 National Health and Nutrition Examination SurveyFood Science & Nutrition, 2021
- Discovery of Intake Biomarkers of Lentils, Chickpeas, and White Beans by Untargeted LC–MS Metabolomics in Serum and UrineMolecular Nutrition & Food Research, 2020
- Tryptophan metabolism in phenylketonuria: A French adult cohort studyJournal of Inherited Metabolic Disease, 2020
- Structural elucidation of novel biomarkers of known metabolic disorders based on multistage fragmentation mass spectraJournal of Inherited Metabolic Disease, 2017
- A Multiplatform Metabolomics Approach to Characterize Plasma Levels of Phenylalanine and Tyrosine in Phenylketonuria2016
- A GC/MS-based metabolomic approach for reliable diagnosis of phenylketonuriaAnalytical and Bioanalytical Chemistry, 2015
- Untargeted metabolomic analysis for the clinical screening of inborn errors of metabolismJournal of Inherited Metabolic Disease, 2015
- Large neutral amino acids in the treatment of PKU: from theory to practiceJournal of Inherited Metabolic Disease, 2010
- l-Carnitine Blood Levels and Oxidative Stress in Treated Phenylketonuric PatientsCellular and Molecular Neurobiology, 2008